Home
NSE: CONCORDDRUGS
Market Cap
NSE: CONCORDDRUGS
Share Price
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
14 Jan 2025 | 37.72 | 37.44 | 37.94 | 34.25 |
13 Jan 2025 | 36.83 | 38 | 38.98 | 36.81 |
10 Jan 2025 | 36.71 | 38.4 | 38.4 | 35.53 |
09 Jan 2025 | 37.87 | 38.95 | 38.95 | 37.24 |
08 Jan 2025 | 37.93 | 38.51 | 38.51 | 36.9 |
07 Jan 2025 | 37.62 | 37.1 | 38.25 | 36.52 |
06 Jan 2025 | 37.38 | 39.79 | 39.79 | 36.01 |
03 Jan 2025 | 38.46 | 40 | 40 | 38 |
02 Jan 2025 | 38.31 | 37.96 | 41 | 37.95 |
01 Jan 2025 | 37.96 | 38.2 | 38.25 | 37.11 |
Date | Price (₹) |
---|---|
14 Jan 2025 | 37.72 |
13 Jan 2025 | 36.83 |
10 Jan 2025 | 36.71 |
09 Jan 2025 | 37.87 |
08 Jan 2025 | 37.93 |
07 Jan 2025 | 37.62 |
06 Jan 2025 | 37.38 |
03 Jan 2025 | 38.46 |
02 Jan 2025 | 38.31 |
01 Jan 2025 | 37.96 |
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical P/E Ratio of Concord Drugs Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical Revenue of Concord Drugs Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical EBITDA of Concord Drugs Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical Net Profit of Concord Drugs Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Net profit of Concord Drugs declined 93.88% to Rs 0.03 crore in the quarter ended June 2024 as again
Read more
2024-08-10 00:00:00
Concord Drugs will hold a meeting of the Board of Directors of the Company on 9 August 2024. Powered
Read more
2024-08-06 00:00:00
Concord Drugs will hold a meeting of the Board of Directors of the Company on 6 September 2024. Powe
Read more
2024-09-03 00:00:00
Concord Drugs announced that the Annual General Meeting (AGM) of the company will be held on 30 Sept
Read more
2024-09-19 00:00:00